European Archives - Page 631 of 1125 - European Medical Journal

Continue
EMJ Cardiology 8.1 2020 Feature Image
October 2020

EMJ Cardiology 8.1 2020

EMJ Cardiology contains an impressive collection of new and interesting research and review articles, alongside our independent review of the European Society of Cardiology (ESC) Congress 2020 with research and breaking news from the virtual event.
EMJ Cardiology 8.1 2020 Feature Image
12 Mins
20 Oct 2020

Review of the European Society of Cardiology (ESC) Congress 2020

FOUNDATIONS comprising more than a million poles, each of which is rooted 12 metres into the ground, support the historic city of Amsterdam, which was set to house this year’s European Society of Cardiology (ESC) Congress before the coronavirus disease (COVID-19) pandemic architectured its transition to a digital experience…
EMJ Cardiology 8.1 2020 Feature Image
1 Mins
20 Oct 2020

Hospital Readmissions After Catheter Ablation for Atrial Fibrillation Among Patients with Heart Failure in the USA

Atrial fibrillation (AF) and congestive heart failure coexist frequently,1 and ablation is increasingly utilised as a safe and effective treatment modality for achieving sinus rhythm in patients with heart failure…
EMJ Cardiology 8.1 2020 Feature Image
1 Mins
20 Oct 2020

Usefulness of the Coronary Artery Calcium Score for Statin Prescription in Primary Prevention: Results in Over 16,000 Assessments

The latest American Heart Association (AHA)/American College of Cardiology (ACC) cholesterol guidelines on primary prevention of coronary artery disease recommend the use of the absolute coronary artery calcium (CAC)-score to help decision making for using statins…
EMJ Cardiology 8.1 2020 Feature Image
3 Mins
20 Oct 2020

2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease

ADVISING individuals with diseases of the heart on what types and intensities of sport to participate in is not a practice…
EMJ Cardiology 8.1 2020 Feature Image
8 Mins
20 Oct 2020

New Insights into Icosapent Ethyl for Patients with Residual Cardiovascular Risk

REDUCE-IT was a Phase IIIb, double-blind, placebo-controlled trial that randomised 8,179 patients to receive icosapent ethyl (4 g/day) or placebo…
EMJ Cardiology 8.1 2020 Feature Image
1 Mins
20 Oct 2020

Spontaneous Coronary Artery Dissection: Contemporary Management and Outcome of a National Cohort

Spontaneous coronary artery dissection (SCAD) is an important cause of acute coronary syndrome (ACS) in predominantly young females. Treatment guidelines advocate conservative treatment of SCAD…
ESC Congress Interview
7 Mins
20 Oct 2020

ESC Congress Interview: Prof Stephan Achenbach, Prof Dan Atar and Prof Jose Zamorano

We cardiologists are proud to have chosen one of the most dynamic and innovative fields of medicine. Few disciplines have encountered similar…
2 Mins
20 Oct 2020

First Clinical Validation of the 0-Hour/1-Hour Algorithm Using High-Sensitivity Cardiac Troponin I for the Diagnosis of Acute Myocardial Infarction in Japanese Patients

Acute myocardial infarction (AMI) is a common and life-threating condition. Approximately 10% of all emergency department (ED)…
EMJ Cardiology 8.1 2020 Feature Image
5 Mins
20 Oct 2020

Key Findings from the EXPLORER-HCM Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: Insights From the Principal Investigator

Hypertrophic cardiomyopathy (HCM) is a progressive myocardial disease that impacts function and quality of life. Patients…
We’ve noticed you’re accessing
from North/South America.